125 related articles for article (PubMed ID: 38099842)
1. Mechanisms of reduced myocardial energetics of the dystrophic heart.
Stevens JA; Dobratz TC; Fischer KD; Palmer A; Bourdage K; Wong AJ; Chapoy-Villanueva H; Garry DJ; Liu JC; Kay MW; Kuzmiak-Glancy S; Townsend D
Am J Physiol Heart Circ Physiol; 2024 Feb; 326(2):H396-H407. PubMed ID: 38099842
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced cardiac injury in dystrophic mice.
Stelter Z; Strakova J; Yellamilli A; Fischer K; Sharpe K; Townsend D
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H938-48. PubMed ID: 26851247
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Myocardial Bioenergetic Deficits: A 9.4 Tesla Complete Non Invasive 31P MR Spectroscopy Study in Mice with Muscular Dystrophy.
Cui W; Jang A; Zhang P; Thompson B; Townsend D; Metzger JM; Zhang J
PLoS One; 2015; 10(8):e0135000. PubMed ID: 26262993
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.
Meyers TA; Townsend D
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443395
[TBL] [Abstract][Full Text] [Related]
5. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
6. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
[TBL] [Abstract][Full Text] [Related]
7. The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration.
Wagner S; Knipp S; Weber C; Hein S; Schinkel S; Walther A; Bekeredjian R; Müller OJ; Friedrich O
J Cell Mol Med; 2012 Dec; 16(12):3028-36. PubMed ID: 22970922
[TBL] [Abstract][Full Text] [Related]
8. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
9. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.
Koenig X; Rubi L; Obermair GJ; Cervenka R; Dang XB; Lukacs P; Kummer S; Bittner RE; Kubista H; Todt H; Hilber K
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H564-H573. PubMed ID: 24337461
[TBL] [Abstract][Full Text] [Related]
10. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.
Au CG; Butler TL; Sherwood MC; Egan JR; North KN; Winlaw DS
Int J Exp Pathol; 2011 Feb; 92(1):57-65. PubMed ID: 21121985
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy.
Murphy S; Dowling P; Zweyer M; Mundegar RR; Henry M; Meleady P; Swandulla D; Ohlendieck K
J Proteomics; 2016 Aug; 145():24-36. PubMed ID: 26961938
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Wilms' Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice.
Guo Z; Geng M; Huang Y; Han G; Jing R; Lin C; Zhang X; Zhang M; Fan G; Wang F; Yin H
Cell Death Differ; 2022 Oct; 29(10):1928-1940. PubMed ID: 35306537
[TBL] [Abstract][Full Text] [Related]
13. Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart.
Haffner V; Nourian Z; Boerman EM; Lambert MD; Hanft LM; Krenz M; Baines CP; Duan D; McDonald KS; Domeier TL
Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1168-H1177. PubMed ID: 37737731
[TBL] [Abstract][Full Text] [Related]
14. Receptor interacting protein kinase-3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy.
Bencze M; Periou B; Punzón I; Barthélémy I; Taglietti V; Hou C; Zaidan L; Kefi K; Blot S; Agbulut O; Gervais M; Derumeaux G; Authier FJ; Tiret L; Relaix F
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2520-2531. PubMed ID: 37909859
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
16. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
[TBL] [Abstract][Full Text] [Related]
17. Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice.
Mareedu S; Fefelova N; Galindo CL; Prakash G; Mukai R; Sadoshima J; Xie LH; Babu GJ
JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564291
[TBL] [Abstract][Full Text] [Related]
18. Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFβ1 signaling in the mdx mouse model of Duchenne muscular dystrophy.
Ieronimakis N; Hays AL; Janebodin K; Mahoney WM; Duffield JS; Majesky MW; Reyes M
J Mol Cell Cardiol; 2013 Oct; 63():122-34. PubMed ID: 23911435
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
20. Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.
Burelle Y; Khairallah M; Ascah A; Allen BG; Deschepper CF; Petrof BJ; Des Rosiers C
J Mol Cell Cardiol; 2010 Feb; 48(2):310-21. PubMed ID: 19769982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
